Cetuximab in combination with radiation therapy and chemotherapy prior to surgery in patients with resectable, locally advanced esophageal carcinoma. A multicenter phase IB-II trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab; Cisplatin; Docetaxel
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2012 Biomarkers information updated
- 08 Jun 2012 Actual end date (1 Nov 2008) added as reported by ClinicalTrials.gov.
- 08 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.